A5024148161- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Vaccine Coverage and Hesitancy
- Long-Term Effects of COVID-19
- Diabetes and associated disorders
- HIV-related health complications and treatments
- Bacterial Infections and Vaccines
- Diphtheria, Corynebacterium, and Tetanus
- HIV/AIDS Research and Interventions
- Medication Adherence and Compliance
- Animal Virus Infections Studies
- Systemic Lupus Erythematosus Research
- COVID-19 epidemiological studies
Padjadjaran University
2021-2024
Dr. Hasan Sadikin General Hospital
2011-2021
COVID-19 infection in high-risk populations is fatal and has a poor prognosis, necessitating test to determine the protectiveness of immune response. Antibody testing necessary body’s response also vaccination strategies. Among various methods available, chemiluminescent immunoassay (CLIA) more widely used accessible antibody levels. This study aimed protection level S-RBD SARS-CoV-2 IgG using CLIA compared Surrogate Virus Neutralization Test (SVNT). The population this comprised all...
In August 2022, Indonesia prioritized healthcare workers to receive the second booster dose. We conducted a sequential serosurvey understand dynamics of antibody titers. The first serosurvey, which was in June 2021, 1-6 months after Sinovac vaccination, showed median level 41.4 BAU/mL (interquartile range (IQR): 10-629.4 BAU/mL). one month (August 2021) Moderna vaccine and 4000 (IQR: 3081-4000 last year 2022) 4000-4000 this survey, only 39 (11.9%) had levels below maximum BAU/mL. Thus, dose,...
COVID-19 infection in high-risk populations is fatal and has a poor prognosis, necessitating test to determine the protectiveness of immune response. Antibody testing necessary body's response also vaccination strategies. Among various methods available, chemiluminescent immunoassay (CLIA) more widely used accessible antibody levels. This study aimed protection level S-RBD SARS-CoV-2 IgG using CLIA compared Surrogate Virus Neutralization Test (SVNT). The population this comprised...
Quantitative determination of anti-SARS-CoV2-S-RBD is necessary for the evaluation vaccination effectiveness. The surrogate viral neutralization test (SVNT) approved measuring anti-SARS-CoV2-S-RBD, but a point-of-care platform needed to simplify anti-SARS-CoV-2-S-RBD measurement. We aimed evaluate performance rapid fluorescent immunoassay-based kit, FastBio-RBDTM, compared SVNT. During April–September 2021, we enrolled two groups subjects, convalescent subjects and without COVID-19 history....
ABSTRACT Healthcare workers in Indonesia acquired a complete 2 doses of Sinovac early 2021 and first booster dose Moderna July 2021. In August 2022, the ministry health prioritized healthcare to acquire second as antibody levels from year before may have waned. We conducted sequential serosurvey aimed determine level SARS CoV2 S-RBD reached by vaccine, after booster, understand dynamics level. COVID-19 test was using FastBioRBD tm with maximum limit detection 4000 BAU/mL. First which June...
Type 2 diabetes mellitus (T2DM) is associated with higher severity and mortality in SARS-CoV-2 infections. Vaccination has been encouraged to boost immunity prevent these unfortunate outcomes. Few studies have evaluated antibody levels after COVID-19 vaccination patients T2DM. Therefore, we examined the status anti-SARS-CoV-2 identify factors that affect This cross-sectional study was conducted at Dr. Hasan Sadikin Hospital Bandung Kiwari Hospital, Bandung, West Java, Indonesia, between...
Abstract Quantitative determination of anti-SARSCoV2-S-RBD is necessary for the evaluation vaccination effectiveness. Surrogate viral neutralization test (SVNT) approved measuring anti-SARSCoV2-S-RBD, but a point-of-care platform needed to simplify anti-SARS-CoV-2-S-RBD measurement. We aimed evaluate performance rapid fluorescent immunoassay-based kit, FastBio-RBD tm , compared SVNT. During April–September 2021, we enrolled two groups subjects; convalescent subject and without COVID-19...
The presence of anti SARS-CoV2-RBD antibody (Anti-RBD) prevents severe COVID-19. We aimed to determine the accuracy a point-of-care Anti-RBD test implemented in person living with HIV (PLWH), systemic lupus erythematosus (SLE), and chronic kidney disease (CKD). enrolled 182 non-comorbid subjects 335 persons comorbid (PLWH, SLE, CKD) anti-RBD assay compared surrogate viral neutralization (SVNT) as reference test. performed linear correlation analysis between vs SVNT ROC analyses ascertain...
The presence of the anti-SARS-CoV-2-RBD antibody (anti-RBD) prevents severe COVID-19. We aimed to determine accuracy a point-of-care anti-RBD testing implemented in persons living with HIV (PLWH), systemic lupus erythematosus (SLE), and chronic kidney disease (CKD). enrolled 182 non-comorbid subjects 335 comorbid (PLWH, SLE, CKD) test assay compared surrogate viral neutralization (sVNT) as reference test. performed linear correlation analysis between sVNT, along an ROC ascertain cutoff at...
We aim to analyze the proportion and level of coronavirus disease 2019 (COVID-19) seropositivity in patients with systemic lupus erythematosus (SLE) explore factors associated lower anti-severe acute respiratory syndrome 2 (SARS-CoV-2) spike receptor-binding domain (S-RBD) antibody levels.
Background: Highly active antiretroviral therapy (HAART) can reduce morbidity and mortality of HIV-infected patients. However, it depends upon adherence to medication. The objective this study was examine the HAART evaluate individual patient characteristics i.e. self-efficacy, depression level, social support finally determine in selected regions Indonesia. Methods: This cross-sectional conducted Jakarta, Malang, Bandung, Makasar Banda Aceh. subject patients who were older than 13 years old...
Negative perception towards vaccination is one of the reasons for low coverage diphtheria immunization in Indonesia. Perception, which difficult to change, related stress level, possibly influences outcome diseases, and also vaccination. This study aims identify correlation between antibody response after used secondary data from two unpublished studies on 30 medical interns Hasan Sadikin Hospital, Bandung, West Java, outbreak, June July 2019. Antibody level emergency was measured using...
Patients with end-stage kidney disease on hemodialysis (ESKD-HD) have a high risk of contracting severe COVID-19. Vaccination can help reduce severity, but the immune dysregulation observed in these patients may result an inadequate antibody response. Therefore, we aimed to evaluate response postvaccination ESKD-HD patients. This prospective cohort study was conducted two centers Indonesia. We enrolled (n = 143) pre- and compared them healthy subjects 67). SARS-CoV-2 assessed using...